Request Information
Targets and Emerging Therapies for Schizophrenia
- Publication Year:
- 2012
- Edition:
- 1st
- Author:
- Albert, Jeffrey S.; Wood, Michael W.
- Publisher:
- Wiley
- ISBN:
- 978-0-47-032282-6
- Doody's Star Rating®:
- Score:
- 67
- Doody Core Title Score:
-
- ()
-
Description
-
Details
Description
Presents new and emerging directions in pharmaceutical research to better treat schizophrenia.
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strat
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strat
Details
- Platform:
- OvidSP
- Publisher:
- Wiley
- Product Type:
- Book
- Author:
- Albert, Jeffrey S.; Wood, Michael W.
- ISBN:
- 978-0-47-032282-6
- Specialty:
-
- Pharmacology
- Pharmaceutical Science
- Psychiatry
- Pharmacy
- Language:
- English
- Edition:
- 1st
- Pages:
- 494
- Publication Year:
- 2012
- Doody's Star Rating®:
- Score:
- 67
- Doody Core Title Score:
-
- ()